These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 15114988)
1. Debate over ritonavir price increase gains momentum. Critics seek to reverse the fivefold price hike through legal action and boycott of Abbott's products. Nelson R Lancet; 2004 Apr; 363(9418):1369. PubMed ID: 15114988 [No Abstract] [Full Text] [Related]
2. Abbott's Norvir price hike is bad medicine. Statement at the NIH public meeting on Norvir. Huff B GMHC Treat Issues; 2004; 18(5-6):10-2. PubMed ID: 15359438 [No Abstract] [Full Text] [Related]
4. Open letter from ATAC to Abbott's CEO, Miles White. Dee L; Sharp M GMHC Treat Issues; 2003 Dec; 17(12):5. PubMed ID: 15011642 [No Abstract] [Full Text] [Related]
5. Backlash over ritonavir price hike. Huff B BETA; 2004; 16(4):15-7. PubMed ID: 15386839 [TBL] [Abstract][Full Text] [Related]
6. Drug pricing. AHF sues Abbott over drug price increase. AIDS Policy Law; 2004 Feb; 19(4):2. PubMed ID: 15045981 [No Abstract] [Full Text] [Related]
7. Controversy over ritonavir price increase. AIDS Clin Care; 2004 Feb; 16(2):15. PubMed ID: 15032179 [No Abstract] [Full Text] [Related]
9. FDA issues warning letter to Abbott over Norvir pricing spin. GMHC Treat Issues; 2004; 18(5-6):11. PubMed ID: 15359439 [No Abstract] [Full Text] [Related]
10. Drug pricing. AHF presses for indemnification over Norvir price increase. AIDS Policy Law; 2004 Feb; 19(4):2. PubMed ID: 15045980 [No Abstract] [Full Text] [Related]
11. Effects of the ritonavir price increase on the cost of protease inhibitor regimens in United States. Lee WC; Williams KW; Chen E; Liu LZ; Pashos CL Manag Care Interface; 2006 Mar; 19(3):27-32. PubMed ID: 16583786 [TBL] [Abstract][Full Text] [Related]